No worries PoS - i was actually going to add a dash with $500k-$1.5m but i thought i'd just use the lower estimate... lol
Just adding on Roche validating the phylomers & this being what i see as the significant factor as opposed to the payment coming forward.
People have liked to use the Aileron partnership as a bit of guidance as to what may be achievable through Roche. Don't forget that Roche was closely watching & part funded Ailerons research 12 months prior to coming out with the $25m up-front / $1.2B milestone deal. Obviously the prior work undertaken also consisted of Roche validating Ailerons technology, similar to where PYC is now standing....
Not saying that the second stage will be that lucrative - but still something worth thinking about.
PYC Price at posting:
6.9¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)